featured
Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)
J. Clin. Oncol 2021 Feb 12;[EPub Ahead of Print], MA Shah, G Bodoky, A Starodub, D Cunningham, D Yip, ZA Wainberg, J Bendell, D Thai, J He, P Bhargava, JA AjaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.